Clinical Study
Pulmonary Hypertension in Dialysis Patients: A Cross-Sectional Italian Study
Table 2
Clinical and laboratory data of patients with and without pulmonary hypertension.
| | PAP 35 | PAP 35 | | | | |
| Age (year) | 59 ± 14 | 61 ± 12 | ns | Male/Female ( (%)) | 22/12 | 15/7 | ns | Diabetes ( (%)) | 1 (3%) | 4 (18%) | 0.05 | Smoking history ( (%)) | 19 (56%) | 17 (77%) | ns | Dialysis vintage (months) | 27 ± 32 | 63 ± 60 | 0.0105 | Dry weight (kg) | 70 ± 16 | 65 ± 13 | ns | Interdialytic weight gain (kg) | 1,3 ± 0,9 | 2,0 ± 1.0 | 0.0168 | Systolic blood pressure (mmHg) | 132 ± 15 | 132 ± 27 | ns | Diastolic blood pressure (mmHg) | 80 ± 8 | 73 ± 12 | 0.0102 | Calcium (mg/dl) | 8,9 ± 1 | 9 ± 1 | ns | Phosphate (mg/dl) | 5,2 ± 1,7 | 5,2 ± 0,9 | ns | Calcium-phosphate product (mg2/dl2) | 48 ± 18 | 48 ± 10 | ns | PTH (pg/ml) | 316 ± 313 | 388 ± 381 | ns | Haemoglobin (gr/dl) | 11,4 ± 1,5 | 11 ± 1,4 | ns | Haematocrit (%) | 36 ± 5 | 34 ± 5 | ns | Erythropoietin (IU/week) | 5980 ± 7664 | 9272 ± 10015 | ns |
|
|